Noninvasive Assessment of Schistosoma-Related Periportal Fibrosis.
abdominal ultrasound
elastography
noninvasive assessment
periportal fibrosis
portal hypertension
schistosomiasis
Journal
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
revised:
18
12
2020
received:
21
09
2020
accepted:
22
12
2020
pubmed:
16
1
2021
medline:
21
10
2021
entrez:
15
1
2021
Statut:
ppublish
Résumé
Schistosomiasis affects nearly 250 million individuals in the world. Hepatosplenic schistosomiasis (HSS) results in periportal fibrosis (PPF) and portal hypertension (pHTN). Ultrasound has been extensively used for the diagnosis of Schistosoma-related PPF and a number of staging methods have been validated for this purpose such as Strickland classification and Niamey protocol. Nevertheless, the application of noninvasive techniques, particularly elastography modalities, has not been well explored. In this review, we describe the various noninvasive diagnostic tools for assessment of Schistosoma-related PPF including US parameters, serum biomarkers, and US-based elastography techniques. While elastography techniques have demonstrated value in the evaluation of HSS, the evidence remains limited with most studies recruiting a small number of patients. Longitudinal studies with larger sample size are required in order to devise robust criteria to accurately assess the performance of noninvasive techniques in the prediction of both regression and progression of the degree of PPF and identify their cost-effectiveness in community screening.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2273-2287Informations de copyright
© 2021 American Institute of Ultrasound in Medicine.
Références
Hotez PJ, Alvarado M, Basáñez MG, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 2014; 8:e2865.
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013 Feb 23;381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added]]. Lancet 2012; 380:2163-2196.
Sarvel AK, Oliveira AA, Silva AR, Lima AC, Katz N. Evaluation of a 25-year-program for the control of schistosomiasis mansoni in an endemic area in Brazil. PLoS Negl Trop Dis 2011; 5:e990.
Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 2009; 373:1570-1575.
Elbaz T, Esmat G. Hepatic and intestinal schistosomiasis: review. J Adv Res 2013; 4:445-452.
Dias HS, Domingues AL, Cordeiro FT, Jucá N, Lopes EP. Associating portal congestive gastropathy and hepatic fibrosis in hepatosplenic mansoni schistosomiasis. Acta Trop 2013; 126:240-243.
Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol 2007; 85:148-154.
Amaral KB, Silva TP, Dias FF, et al. Histological assessment of granulomas in natural and experimental Schistosoma mansoni infections using whole slide imaging. PLoS One 2017; 12:e0184696.
Gasim GI, Bella A, Adam I. Schistosomiasis, hepatitis B and hepatitis C co-infection. Virol J 2015; 12:19.
Kamal SM, Turner B, He Q, et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 2006; 43:771-779.
Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
Bärenbold O, Raso G, Coulibaly JT, N'Goran EK, Utzinger J, Vounatsou P. Estimating sensitivity of the Kato-Katz technique for the diagnosis of Schistosoma mansoni and hookworm in relation to infection intensity. PLoS Negl Trop Dis 2017; 11:e0005953.
Sorgho H, Bahgat M, Poda JN, et al. Serodiagnosis of Schistosoma mansoni infections in an endemic area of Burkina Faso: performance of several immunological tests with different parasite antigens. Acta Trop 2005; 93:169-180.
Gray DJ, Ross AG, Li YS, McManus DP. Diagnosis and management of schistosomiasis. BMJ 2011; 342:d2651.
Weerakoon KG, Gordon CA, McManus DP. DNA diagnostics for Schistosomiasis control. Trop Med Infect Dis 2018; 3:81.
Silva LC, Andrade LM, Queiroz LC, et al. Schistosoma mansoni: magnetic resonance analysis of liver fibrosis according to WHO patterns for ultrasound assessment of schistosomiasis-related morbidity. Memorias do Instituto Oswaldo Cruz 2010; 105:467-470.
Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity. Geneva: World Health Organization; 2000:49.
Richter J, Botelho MC, Holtfreter MC, et al. Ultrasound assessment of schistosomiasis. Sonografische Diagnostik der Schistosomiasis (Bilharziose). Z Gastroenterol 2016; 54:653-660.
Domingues AL, Medeiros TB, Lopes EP. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni. Mem Inst Oswaldo Cruz 2011; 106:802-807.
Hussain S, Hawass ND, Zaidi AJ. Ultrasonographic diagnosis of schistosomal periportal fibrosis. J Ultrasound Med 1984; 3:449-452.
Abdel-Wahab MF, Esmat G, Farrag A, el-Boraey YA, Strickland GT. Grading of hepatic schistosomiasis by the use of ultrasonography. Am J Trop Med Hyg 1992; 46:403-408.
Homeida M, Abdel-Gadir AF, Cheever AW, et al. Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. Am J Trop Med Hyg 1998; 38:86-91.
Santos GT, Sales DM, ARdS L, et al. Reproducibility of ultrasonography in the assessment of periportal fibrosis according to Niamey criteria in patients with schistosomiasis mansoni. Radiol Bras 2007; 40:377-381.
Marinho CC, Nicolato AJPG, Reis VW, et al. Ultrasound evaluation of schistosomiasis-related morbidity among the Xakriabá people in the state of Minas Gerais, Brazil. Radiol Bras 2020; 53:7-13.
Kardorff R, Olveda RM, Acosta LP, et al. Hepatosplenic morbidity in schistosomiasis japonica: evaluation with Doppler sonography. Am J Trop Med Hyg 1999; 60:954-959.
Sah VK, Wang L, Min X, et al. Human schistosomiasis: a diagnostic imaging focused review of a neglected disease. Radiol Infect Dis 2015; 2:150-157.
Fataar S, Bassiony H, Satyanath S, et al. CT of hepatic schistosomiasis mansoni. AJR Am J Roentgenol 1985; 145:63-66.
Willemsen UF, Pfluger T, Zoller WG, Kueffer G, Hahn K. MRI of hepatic schistosomiasis mansoni. J Comput Assist Tomogr 1995; 19:811-813.
Giannini E, Botta F, Borro P, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52:1200-1205.
Chen R, Deng H, Ding X, Xie C, Wang W, Shen Q. Platelet count to spleen diameter ratio for the diagnosis of Gastroesophageal Varices in liver cirrhosis: a systematic review and meta-analysis. Gastroenterol Res Pract 2017; 2017:7407506.
Agha A, Abdulhadi MM, Marenco S, et al. Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol 2011; 17:307-311.
Xu XD, Xu CF, Dai JJ, Qian JQ, Pin X. Ratio of platelet count/spleen diameter predicted the presence of esophageal varices in patients with schistosomiasis liver cirrhosis. Eur J Gastroenterol Hepatol 2016; 28:588-591.
Hassan MA, Abass AM, Mirghani HO, et al. Noninvasive prediction of esophageal Varices grade (size) in Sudanese patients with Periportal fibrosis. Int J Gastroenterol 2018; 12:28-33.
Medeiros TB, Domingues AL, Luna CF, Lopes EP. Correlation between platelet count and both liver fibrosis and spleen diameter in patients with schistosomiasis mansoni. Arq Gastroenterol 2014; 51:34-38.
Derbala M, Elbadri ME, Amer AM, et al. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection. World J Gastroenterol 2015; 21:13132.
Hou XY, Ellis MK, McManus DP, et al. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica. Int J Parasitol 2011; 41:325-332.
Wu YM, Xu N, Hu JY, et al. A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica. Parasitol Int 2013; 62:283-288.
Marinho CC, Bretas T, Voieta I, et al. Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil. Mem Inst Oswaldo Cruz 2010; 105:471-478.
Silva CC, Domingues AL, Lopes EP, et al. Schistosomiasis mansoni: ultrasound-evaluated hepatic fibrosis and serum concentrations of hyaluronic acid. Ann Trop Med Parasitol 2011; 105:233-239.
Barreto AV, Alecrim VM, Medeiros TB, et al. New index for the diagnosis of liver fibrosis in Schistosomiasis mansoni [published correction appears in Arq Gastroenterol. 2019 May 20;56(1):108-109]. Arq Gastroenterol 2017; 54:51-56.
Shiha G, Samir W, Soliman R, Elbasiony M, Ahmed N, Helmy A. Transient Elastography (TE) is not useful in the diagnosis of schistosomal hepatic fibrosis. Med J Viral Hepat 2016; 1:23-32. https://doi.org/10.21608/mjvh.2016.4568.
Ramzy I, Elsharkawy A, Fouad R, et al. Impact of old Schistosomiasis infection on the use of transient elastography (Fibroscan) for staging of fibrosis in chronic HCV patients. Acta Trop 2017; 176:283-287.
Esmat G, Elsharkawy A, El Akel W, et al. Fibroscan of chronic HCV patients coinfected with schistosomiasis. Arab J Gastroenterol 2013; 14:109-112.
Parris V, Michie K, Andrews T, et al. Schistosomiasis japonicum diagnosed on liver biopsy in a patient with hepatitis B co-infection: a case report. J Med Case Reports 2014; 8:45.
Veiga ZST, Villela-Nogueira CA, Fernandes FF, et al. Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis. Eur J Gastroenterol Hepatol 2017; 29:730-735.
Lima LMSTB, Lacet CMC, Parise ER. Evaluation of hepatic fibrosis by elastography in patients with schistosomiasis mansoni. Trans R Soc Trop Med Hyg 2020; 114:531-537.
R Carvalho Santos J, Dória Batista A, Maria Mola Vasconcelos C, et al. Liver ultrasound elastography for the evaluation of periportal fibrosis in schistosomiasis mansoni: a cross-sectional study. PLoS Negl Trop Dis 2018; 12:e0006868.
Nascimento M, Filho G, Andrade M, et al. Correlation among three non-invasive methods (apri, fib-4 and transient elastography) to evaluate liver function and stiffness in patients with viral hepatitis c or schistosomiasis mansoni. J Trop Path 2018; 47:100. https://doi.org/10.5216/rpt.v47i2.53679.
Wu S, Tseng Y, Xu N, et al. Evaluation of transient elastography in assessing liver fibrosis in patients with advanced schistosomiasis japonica. Parasitol Int 2018; 67:302-308.